How to diagnose and treat amyloidosis?

10' education - Sep. 1, 2020 - Prof. Peter van der Meer, MD, PhD - UMCG, Groningen, The Netherlands

Video navigation menu

Case presentation 00:37
Which characteristics increase suspicion for ATTRwt? 06:24
Diagnostic algorithm 07:24
Targets of therapy 09:24
Trials outcomes (ATTR-ACT and APOLLO trial) 11:09

Educational information

This video by prof. Van der Meer, MD, PhD is part of the 3rd Groningen Heart Failure symposium "How to implement the newest heart failiure therapies? - A case-based approach".

Faculty

Prof. van der Meer received both this MD and PhD cum laude from the University of Groningen in the Netherlands and worked as a visiting scientist at Harvard Medical School, Boston, MA, USA. He is a cardiologist and director of the coronary care unit at the UMCG, Groningen, The Netherlands. His research-group consists of PhD students and post-docs with various backgrounds working on (translational) research topics.

Disclosures

This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.

Funding

Funding for this educational program was provided by unrestricted educational grants from AstraZeneca, Pfizer, Vifor and Novartis.

Click here for the introduction of this symposium Watch other presentations in this series

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.